Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
SoniVie
SoniVie Overview
SoniVie Climate Tech relevance
undefined
Suggested Companies
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 9, 2023
en.globes.co.il
Israeli medical device co SoniVie raises $60m
#Investment
Jul 13, 2022
www.prnewswire.com
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
#Customers
Jun 24, 2022
www.jpost.com
Israeli company SoniVie receives FDA approval for innovative hypertension treatment
#Investment
Dec 9, 2020
www.globenewswire.com
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System for Renal Artery Denervation
#Acquisition
Oct 13, 2020
www.globenewswire.com
SoniVie Receives IDE Approval for its Pivotal Study for the TIVUS System to Treat Patients with Pulmonary Arterial Hypertension (PAH)
#Customers
Sep 6, 2019
markets.businessinsider.com
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System in the Treatment of Pulmonary Arterial Hypertension (PAH)
#Customers
Jun 5, 2019
www.mddionline.com
New System Could Hold Promise for Patients Suffering from Pulmonary Arterial Hypertension
undefined
May 23, 2019
www.techwald.com
SoniVie Presents Clinical Trial Data Supporting the Safety and Efficacy of the TIVUS™ System in the Treatment of Pulmonary Arterial Hypertension - TechWald Holding S.p.A.
#Customers
May 20, 2019
www.prweb.com
SoniVie Appoints Charles Carignan, MD, Chief Executive Officer and Announces Upcoming Presentation of TIVUS™ Clinical Trial Data at EuroPCR 2019
#Management Changes #Customers
Mar 8, 2016
www.globes.co.il
SoniVie completes first PAH catheter procedures
#Customers
Mar 8, 2016
www.prnewswire.com
SoniVie, a Portfolio Company of Accelmed Fund, Announces Successful Completion of First-In-Human Procedures Using the TIVUS Catheter
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
#Customers
Jun 24, 2022
www.jpost.com
Israeli company SoniVie receives FDA approval for innovative hypertension treatment
#Investment
Dec 9, 2020
www.globenewswire.com
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System for Renal Artery Denervation
#Acquisition
Oct 13, 2020
www.globenewswire.com
SoniVie Receives IDE Approval for its Pivotal Study for the TIVUS System to Treat Patients with Pulmonary Arterial Hypertension (PAH)
#Customers
Sep 6, 2019
markets.businessinsider.com
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System in the Treatment of Pulmonary Arterial Hypertension (PAH)
#Customers
Jun 5, 2019
www.mddionline.com
New System Could Hold Promise for Patients Suffering from Pulmonary Arterial Hypertension
undefined
May 23, 2019
www.techwald.com
SoniVie Presents Clinical Trial Data Supporting the Safety and Efficacy of the TIVUS™ System in the Treatment of Pulmonary Arterial Hypertension - TechWald Holding S.p.A.
#Customers
May 20, 2019
www.prweb.com
SoniVie Appoints Charles Carignan, MD, Chief Executive Officer and Announces Upcoming Presentation of TIVUS™ Clinical Trial Data at EuroPCR 2019
#Management Changes #Customers
Mar 8, 2016
www.globes.co.il
SoniVie completes first PAH catheter procedures
#Customers
Mar 8, 2016
www.prnewswire.com
SoniVie, a Portfolio Company of Accelmed Fund, Announces Successful Completion of First-In-Human Procedures Using the TIVUS Catheter
#Investment
Nov 3, 2015
news.nocamels.com
SoniVie Raises $2.5M From Accelmed
#Investment
View other companies you might be interested in
SoniVie Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.